{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:54:32Z","timestamp":1794488072771,"version":"4.9.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS082174"],"award-info":[{"award-number":["NS082174"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["AG00096"],"award-info":[{"award-number":["AG00096"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["AG000096"],"award-info":[{"award-number":["AG000096"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"name":"HD Care"},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer\u2019s Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["RT3-07893"],"award-info":[{"award-number":["RT3-07893"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["AG016573"],"award-info":[{"award-number":["AG016573"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Susan Scott Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The discovery of TREM2 as a myeloid-specific Alzheimer\u2019s disease (AD) risk gene has accelerated research into the role of microglia in AD. While TREM2 mouse models have provided critical insight, the normal and disease-associated functions of TREM2 in human microglia remain unclear. To examine this question, we profile microglia differentiated from isogenic, CRISPR-modified TREM2-knockout induced pluripotent stem cell (iPSC) lines. By combining transcriptomic and functional analyses with a chimeric AD mouse model, we find that TREM2 deletion reduces microglial survival, impairs phagocytosis of key substrates including APOE, and inhibits SDF-1\u03b1\/CXCR4-mediated chemotaxis, culminating in an impaired response to beta-amyloid plaques in vivo. Single-cell sequencing of xenotransplanted human microglia further highlights a loss of disease-associated microglial (DAM) responses in human TREM2 knockout microglia that we validate by flow cytometry and immunohistochemistry. Taken together, these studies reveal both conserved and novel aspects of human TREM2 biology that likely play critical roles in the development and progression of AD.<\/jats:p>","DOI":"10.1038\/s41467-020-19227-5","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T06:04:28Z","timestamp":1603433068000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":356,"title":["Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5368-6788","authenticated-orcid":false,"given":"Amanda","family":"McQuade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You Jung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2630-9850","authenticated-orcid":false,"given":"Jonathan","family":"Hasselmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Jairaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Sotelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Coburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh Kiani","family":"Shabestari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Paul","family":"Chadarevian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianna","family":"Fote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina H.","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Danhash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Cotman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Aleph","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan S.","family":"Steffan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9910-195X","authenticated-orcid":false,"given":"Ian","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8554-6456","authenticated-orcid":false,"given":"Hayk","family":"Davtyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Cahalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1829-2462","authenticated-orcid":false,"given":"Hansang","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7770-7157","authenticated-orcid":false,"given":"Mathew","family":"Blurton-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,23]]},"reference":[{"key":"19227_CR1","doi-asserted-by":"publisher","unstructured":"Jansen, I. E. et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat. Genet. https:\/\/doi.org\/10.1038\/s41588-018-0311-9 (2019).","DOI":"10.1038\/s41588-018-0311-9"},{"key":"19227_CR2","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert, J. C. et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat. Genet. 45, 1452\u20131458 (2013).","journal-title":"Nat. Genet."},{"key":"19227_CR3","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/j.jmb.2019.01.045","volume":"431","author":"A McQuade","year":"2019","unstructured":"McQuade, A. & Blurton-Jones, M. Microglia in Alzheimer\u2019s disease: Exploring how genetics and phenotype influence risk. J. Mol. Biol. 431, 1805\u20131817 (2019).","journal-title":"J. Mol. Biol."},{"key":"19227_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson, T. et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N. Engl. J. Med. 368, 107\u2013116 (2013).","journal-title":"N. Engl. J. Med."},{"key":"19227_CR5","doi-asserted-by":"publisher","unstructured":"Shi, Y. & Holtzman, D. M. Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight. Nat. Rev. Immunol. https:\/\/doi.org\/10.1038\/s41577-018-0051-1 (2018).","DOI":"10.1038\/s41577-018-0051-1"},{"key":"19227_CR6","doi-asserted-by":"publisher","first-page":"594","DOI":"10.4049\/jimmunol.171.2.594","volume":"171","author":"MR Daws","year":"2003","unstructured":"Daws, M. R. et al. Pattern recognition by TREM-2: binding of anionic ligands. J. Immunol. 171, 594\u2013599 (2003).","journal-title":"J. Immunol."},{"key":"19227_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1083\/jcb.200808080","volume":"184","author":"E-N N\u2019Diaye","year":"2009","unstructured":"N\u2019Diaye, E.-N. et al. TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria. J. Cell Biol. 184, 215\u2013223 (2009).","journal-title":"J. Cell Biol."},{"key":"19227_CR8","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"160","author":"Y Wang","year":"2015","unstructured":"Wang, Y. et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model. Cell 160, 1061\u20131071 (2015).","journal-title":"Cell"},{"key":"19227_CR9","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.neuron.2018.01.031","volume":"97","author":"Y Zhao","year":"2018","unstructured":"Zhao, Y. et al. TREM2 is a receptor for \u03b2-amyloid that mediates microglial function. Neuron 97, 1023\u20131031.e7 (2018).","journal-title":"Neuron"},{"key":"19227_CR10","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1084\/jem.194.8.1111","volume":"194","author":"A Bouchon","year":"2001","unstructured":"Bouchon, A., Hern\u00e1ndez-Munain, C., Cella, M. & Colonna, M. A Dap12-mediated pathway regulates expression of cc chemokine receptor 7 and maturation of human dendritic cells. J. Exp. Med. 194, 1111\u20131122 (2001).","journal-title":"J. Exp. Med."},{"key":"19227_CR11","doi-asserted-by":"publisher","first-page":"12620","DOI":"10.1074\/jbc.RA118.001848","volume":"293","author":"Q Cheng","year":"2018","unstructured":"Cheng, Q. et al. TREM2-activating antibodies abrogate the negative pleiotropic effects of the Alzheimer\u2019s disease variant Trem2R47H on murine myeloid cell function. J. Biol. Chem. 293, 12620\u201312633 (2018).","journal-title":"J. Biol. Chem."},{"key":"19227_CR12","doi-asserted-by":"publisher","unstructured":"Parhizkar, S. et al. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nat. Neurosci. https:\/\/doi.org\/10.1038\/s41593-018-0296-9 (2019).","DOI":"10.1038\/s41593-018-0296-9"},{"key":"19227_CR13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.neurobiolaging.2016.03.004","volume":"42","author":"H Zheng","year":"2016","unstructured":"Zheng, H. et al. Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation. Neurobiol. Aging 42, 132\u2013141 (2016).","journal-title":"Neurobiol. Aging"},{"key":"19227_CR14","doi-asserted-by":"publisher","first-page":"934.e7","DOI":"10.1016\/j.neurobiolaging.2013.09.017","volume":"35","author":"B Borroni","year":"2014","unstructured":"Borroni, B. et al. Heterozygous TREM2 mutations in frontotemporal dementia. Neurobiol. Aging 35, 934.e7\u201310 (2014).","journal-title":"Neurobiol. Aging"},{"key":"19227_CR15","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jalz.2016.07.004","volume":"13","author":"W Song","year":"2017","unstructured":"Song, W. et al. Alzheimer\u2019s disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation. Alzheimer\u2019s Dement. 13, 381\u2013387 (2017).","journal-title":"Alzheimer\u2019s Dement."},{"key":"19227_CR16","doi-asserted-by":"publisher","first-page":"726.e11","DOI":"10.1016\/j.neurobiolaging.2013.09.009","volume":"35","author":"E Cuyvers","year":"2014","unstructured":"Cuyvers, E. et al. Investigating the role of rare heterozygous TREM2 variants in Alzheimer\u2019s disease and frontotemporal dementia. Neurobiol. Aging 35, 726.e11\u201319 (2014).","journal-title":"Neurobiol. Aging"},{"key":"19227_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13024-015-0016-9","volume":"10","author":"SC Jin","year":"2015","unstructured":"Jin, S. C. et al. TREM2 is associated with increased risk for Alzheimer\u2019s disease in African Americans. Mol. Neurodegener. 10, 19 (2015).","journal-title":"Mol. Neurodegener."},{"key":"19227_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-017-0216-6","volume":"12","author":"SM Bemiller","year":"2017","unstructured":"Bemiller, S. M. et al. TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy. Mol. Neurodegeneration 12, 74 (2017).","journal-title":"Mol. Neurodegeneration"},{"key":"19227_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13024-018-0262-8","volume":"13","author":"PJ Cheng-Hathaway","year":"2018","unstructured":"Cheng-Hathaway, P. J. et al. The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer\u2019s disease. Mol. Neurodegener. 13, 29 (2018).","journal-title":"Mol. Neurodegener."},{"key":"19227_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13024-018-0280-6","volume":"13","author":"X Xiang","year":"2018","unstructured":"Xiang, X. et al. The Trem2 R47H Alzheimer\u2019s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans. Mol. Neurodegener. 13, 49 (2018).","journal-title":"Mol. Neurodegener."},{"key":"19227_CR21","doi-asserted-by":"publisher","unstructured":"Kang, S. S. et al. Microglial translational profiling reveals a convergent APOE pathway from aging, amyloid, and tau. J. Exp. Med. https:\/\/doi.org\/10.1084\/jem.20180653 (2018).","DOI":"10.1084\/jem.20180653"},{"key":"19227_CR22","doi-asserted-by":"publisher","first-page":"11524","DOI":"10.1073\/pnas.1710311114","volume":"114","author":"CEG Leyns","year":"2017","unstructured":"Leyns, C. E. G. et al. TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy. Proc. Natl Acad. Sci. USA 114, 11524\u201311529 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"19227_CR23","doi-asserted-by":"publisher","unstructured":"Hammond, T. R., Robinton, D. & Stevens, B. Microglia and the brain: complementary partners in development and disease. Annu. Rev. Cell Dev. Biol. https:\/\/doi.org\/10.1146\/annurev-cellbio-100616-060509 (2018).","DOI":"10.1146\/annurev-cellbio-100616-060509"},{"key":"19227_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1750-1326-9-20","volume":"9","author":"JD Ulrich","year":"2014","unstructured":"Ulrich, J. D. et al. Altered microglial response to A\u03b2 plaques in APPPS1-21 mice heterozygous for TREM2. Mol. Neurodegener. 9, 20 (2014).","journal-title":"Mol. Neurodegener."},{"key":"19227_CR25","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1084\/jem.20160844","volume":"214","author":"L Zhong","year":"2017","unstructured":"Zhong, L. et al. Soluble TREM2 induces inflammatory responses and enhances microglial survival. J. Exp. Med. 214, 597\u2013607 (2017).","journal-title":"J. Exp. Med."},{"key":"19227_CR26","doi-asserted-by":"publisher","unstructured":"Hasselmann, J. et al. Development of a chimeric model to study and manipulate human microglia in vivo. Neuron https:\/\/doi.org\/10.1016\/j.neuron.2019.07.002 (2019).","DOI":"10.1016\/j.neuron.2019.07.002"},{"key":"19227_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-018-0297-x","volume":"13","author":"A McQuade","year":"2018","unstructured":"McQuade, A. et al. Development and validation of a simplified method to generate human microglia from pluripotent stem cells. Mol. Neurodegeneration 13, 67 (2018).","journal-title":"Mol. Neurodegeneration"},{"key":"19227_CR28","unstructured":"M, H. et al. Glycoprotein NMB: a novel Alzheimer\u2019s disease associated marker expressed in a subset of activated microglia. Acta Neuropathol. Commun. https:\/\/pubmed.ncbi.nlm.nih.gov\/30340518\/ (2018)."},{"key":"19227_CR29","unstructured":"Cf, Y. et al. Loss of GPNMB causes autosomal-recessive amyloidosis cutis dyschromica in humans. Am. J. Human Genet. https:\/\/pubmed.ncbi.nlm.nih.gov\/29336782\/?from_single_result=29336782&expanded_search_query=29336782 (2018)."},{"key":"19227_CR30","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann, S. et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47, e9 (2017).","journal-title":"Immunity"},{"key":"19227_CR31","unstructured":"L, F. et al. TAM receptors regulate multiple features of microglial physiology. Nature https:\/\/pubmed.ncbi.nlm.nih.gov\/27049947\/?from_single_result=27049947&expanded_search_query=27049947 (2016)."},{"key":"19227_CR32","unstructured":"Mm, V. et al. A split-luciferase complementation, real-time reporting assay enables monitoring of the disease-associated transmembrane protein TREM2 in live cells. J. Biol. Chem. https:\/\/pubmed.ncbi.nlm.nih.gov\/28490631\/?from_single_result=28490631&expanded_search_query=28490631 (2017)."},{"key":"19227_CR33","doi-asserted-by":"crossref","unstructured":"Wang, S. et al. Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer\u2019s disease model. J. Exp. Med. 217, e20200785 (2020).","DOI":"10.1084\/jem.20200785"},{"key":"19227_CR34","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1523\/JNEUROSCI.2459-16.2017","volume":"37","author":"H Zheng","year":"2017","unstructured":"Zheng, H. et al. TREM2 Promotes microglial survival by activating Wnt\/\u03b2-catenin pathway. J. Neurosci. 37, 1772\u20131784 (2017).","journal-title":"J. Neurosci."},{"key":"19227_CR35","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/ni.1744","volume":"10","author":"K Otero","year":"2009","unstructured":"Otero, K. et al. Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and \u03b2-catenin. Nat. Immunol. 10, 734\u2013743 (2009).","journal-title":"Nat. Immunol."},{"key":"19227_CR36","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.4049\/jimmunol.1102836","volume":"188","author":"K Otero","year":"2012","unstructured":"Otero, K. et al. TREM2 and \u03b2-catenin regulate bone homeostasis by controlling the rate of osteoclastogenesis. J. Immunol. 188, 2612\u20132621 (2012).","journal-title":"J. Immunol."},{"key":"19227_CR37","doi-asserted-by":"crossref","unstructured":"Sosna, J. et al. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer\u2019s disease. Mol. Neurodegener. 13, 11 (2018).","DOI":"10.1186\/s13024-018-0244-x"},{"key":"19227_CR38","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","volume":"91","author":"FL Yeh","year":"2016","unstructured":"Yeh, F. L., Wang, Y., Tom, I., Gonzalez, L. C. & Sheng, M. TREM2 Binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-beta by microglia. Neuron 91, 328\u2013340 (2016).","journal-title":"Neuron"},{"key":"19227_CR39","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.immuni.2018.04.016","volume":"48","author":"F Filipello","year":"2018","unstructured":"Filipello, F. et al. The microglial innate immune receptor TREM2 is required for synapse elimination and normal brain connectivity. Immunity 48, 979\u2013991.e8 (2018).","journal-title":"Immunity"},{"key":"19227_CR40","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.neuron.2017.03.042","volume":"94","author":"EM Abud","year":"2017","unstructured":"Abud, E. M. et al. iPSC-Derived human microglia-like cells to study neurological diseases. Neuron 94, 278\u2013293.e9 (2017).","journal-title":"Neuron"},{"key":"19227_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3030","volume":"4","author":"D Frenkel","year":"2013","unstructured":"Frenkel, D. et al. Scara1 deficiency impairs clearance of soluble amyloid-\u03b2 by mononuclear phagocytes and accelerates Alzheimer\u2019s-like disease progression. Nat. Commun. 4, 2030 (2013).","journal-title":"Nat. Commun."},{"key":"19227_CR42","doi-asserted-by":"publisher","first-page":"9838","DOI":"10.1523\/JNEUROSCI.2557-04.2004","volume":"24","author":"J Koenigsknecht","year":"2004","unstructured":"Koenigsknecht, J. & Landreth, G. Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism. J. Neurosci. 24, 9838\u20139846 (2004).","journal-title":"J. Neurosci."},{"key":"19227_CR43","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1084\/jem.20151948","volume":"213","author":"Y Wang","year":"2016","unstructured":"Wang, Y. et al. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J. Exp. Med. 213, 667\u2013675 (2016).","journal-title":"J. Exp. Med."},{"key":"19227_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7176","volume":"6","author":"C Condello","year":"2015","unstructured":"Condello, C., Yuan, P., Schain, A. & Grutzendler, J. Microglia constitute a barrier that prevents neurotoxic protofibrillar A\u03b242 hotspots around plaques. Nat. Commun. 6, 6176 (2015).","journal-title":"Nat. Commun."},{"key":"19227_CR45","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.neuron.2016.05.003","volume":"90","author":"P Yuan","year":"2016","unstructured":"Yuan, P. et al. TREM2 Haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron 90, 724\u2013739 (2016).","journal-title":"Neuron"},{"key":"19227_CR46","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/s41593-018-0175-4","volume":"21","author":"J Park","year":"2018","unstructured":"Park, J. et al. A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer\u2019s disease. Nat. Neurosci. 21, 941\u2013951 (2018).","journal-title":"Nat. Neurosci."},{"key":"19227_CR47","doi-asserted-by":"crossref","unstructured":"Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169, 1276\u20131290 (2017).","DOI":"10.1016\/j.cell.2017.05.018"},{"key":"19227_CR48","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nm.4298","volume":"23","author":"B Guo","year":"2017","unstructured":"Guo, B., Huang, X., Cooper, S. & Broxmeyer, H. E. Glucocorticoid hormone-induced chromatin remodeling enhances human hematopoietic stem cell homing and engraftment. Nat. Med. 23, 424\u2013428 (2017).","journal-title":"Nat. Med."},{"key":"19227_CR49","doi-asserted-by":"publisher","first-page":"24789","DOI":"10.1074\/jbc.M800649200","volume":"283","author":"Y Luo","year":"2008","unstructured":"Luo, Y., Lathia, J., Mughal, M. & Mattson, M. P. SDF1\u03b1\/CXCR4 Signaling, via ERKs and the transcription factor Egr1, induces expression of a 67-kDa form of glutamic acid decarboxylase in embryonic hippocampal neurons. J. Biol. Chem. 283, 24789\u201324800 (2008).","journal-title":"J. Biol. Chem."},{"key":"19227_CR50","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","volume":"34","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 34, 11929\u201311947 (2014).","journal-title":"J. Neurosci."},{"key":"19227_CR51","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.brainres.2012.04.011","volume":"1459","author":"Q Wang","year":"2012","unstructured":"Wang, Q. et al. Stromal cell-derived factor 1\u03b1 decreases \u03b2-amyloid deposition in Alzheimer\u2019s disease mouse model. Brain Res. 1459, 15\u201326 (2012).","journal-title":"Brain Res."},{"key":"19227_CR52","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/nm0198-072","volume":"4","author":"GA Donzella","year":"1998","unstructured":"Donzella, G. A. et al. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nat. Med. 4, 72\u201377 (1998).","journal-title":"Nat. Med."},{"key":"19227_CR53","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1038\/s41593-019-0525-x","volume":"22","author":"R Mancuso","year":"2019","unstructured":"Mancuso, R. et al. Stem-cell-derived human microglia transplanted in mouse brain to study human disease. Nat. Neurosci. 22, 2111\u20132116 (2019).","journal-title":"Nat. Neurosci."},{"key":"19227_CR54","doi-asserted-by":"publisher","unstructured":"Mathys, H. et al. Single-cell transcriptomic analysis of Alzheimer\u2019s disease. Nature https:\/\/doi.org\/10.1038\/s41586-019-1195-2 (2019).","DOI":"10.1038\/s41586-019-1195-2"},{"key":"19227_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2018.142","volume":"5","author":"PL De Jager","year":"2018","unstructured":"De Jager, P. L. et al. A multi-omic atlas of the human frontal cortex for aging and Alzheimer\u2019s disease research. Sci. Data 5, 180142 (2018).","journal-title":"Sci. Data"},{"key":"19227_CR56","doi-asserted-by":"publisher","first-page":"26043","DOI":"10.1074\/jbc.M115.679043","volume":"290","author":"Y Atagi","year":"2015","unstructured":"Atagi, Y. et al. Apolipoprotein E is a ligand for triggering receptor expressed on myeloid cells 2 (TREM2). J. Biol. Chem. 290, 26043\u201326050 (2015).","journal-title":"J. Biol. Chem."},{"key":"19227_CR57","doi-asserted-by":"publisher","first-page":"26033","DOI":"10.1074\/jbc.M115.677286","volume":"290","author":"CC Bailey","year":"2015","unstructured":"Bailey, C. C., DeVaux, L. B. & Farzan, M. The triggering receptor expressed on myeloid cells 2 binds apolipoprotein E. J. Biol. Chem. 290, 26033\u201326042 (2015).","journal-title":"J. Biol. Chem."},{"key":"19227_CR58","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1182\/blood-2005-03-1239","volume":"106","author":"DM Underhill","year":"2005","unstructured":"Underhill, D. M., Rossnagle, E., Lowell, C. A. & Simmons, R. M. Dectin-1 activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production. Blood 106, 2543\u20132550 (2005).","journal-title":"Blood"},{"key":"19227_CR59","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2174\/138945008783502430","volume":"9","author":"JS Schorey","year":"2008","unstructured":"Schorey, J. S. & Lawrence, C. The pattern recognition receptor Dectin-1: from fungi to mycobacteria. Curr. Drug Targets 9, 123\u2013129 (2008).","journal-title":"Curr. Drug Targets"},{"key":"19227_CR60","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong, S. et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352, 712\u2013716 (2016).","journal-title":"Science"},{"key":"19227_CR61","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/978-3-030-38266-7_8","volume":"1233","author":"LD Harris","year":"2020","unstructured":"Harris, L. D., Jasem, S. & Licchesi, J. D. F. The ubiquitin system in Alzheimer\u2019s disease. Adv. Exp. Med. Biol. 1233, 195\u2013221 (2020).","journal-title":"Adv. Exp. Med. Biol."},{"key":"19227_CR62","doi-asserted-by":"publisher","first-page":"15566","DOI":"10.1074\/jbc.M110.103408","volume":"285","author":"V Saini","year":"2010","unstructured":"Saini, V., Marchese, A. & Majetschak, M. CXC chemokine receptor 4 is a cell surface receptor for extracellular ubiquitin. J. Biol. Chem. 285, 15566\u201315576 (2010).","journal-title":"J. Biol. Chem."},{"key":"19227_CR63","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13195-019-0508-x","volume":"11","author":"S Zhang","year":"2019","unstructured":"Zhang, S. et al. Upregulation of MIF as a defense mechanism and a biomarker of Alzheimer\u2019s disease. Alzheimer\u2019s Res. Ther. 11, 54 (2019).","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"19227_CR64","doi-asserted-by":"publisher","first-page":"7817","DOI":"10.1523\/JNEUROSCI.6412-10.2011","volume":"31","author":"S Lee","year":"2011","unstructured":"Lee, S., Sato, Y. & Nixon, R. A. Lysosomal proteolysis inhibition selectively disrupts axonal transport of degradative organelles and causes an Alzheimer\u2019s-like axonal dystrophy. J. Neurosci. 31, 7817\u20137830 (2011).","journal-title":"J. Neurosci."},{"key":"19227_CR65","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1007\/s11064-019-02748-x","volume":"44","author":"J Zhou","year":"2019","unstructured":"Zhou, J. et al. Imbalance of microglial TLR4\/TREM2 in LPS-treated APP\/PS1 transgenic mice: a potential link between Alzheimer\u2019s disease and systemic inflammation. Neurochem. Res. 44, 1138\u20131151 (2019).","journal-title":"Neurochem. Res."},{"key":"19227_CR66","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.neuron.2019.07.002","volume":"103","author":"J Hasselmann","year":"2019","unstructured":"Hasselmann, J. et al. Development of a chimeric model to study and manipulate human microglia in vivo. Neuron 103, 1016\u20131033\u00a0(2019).","journal-title":"Neuron"},{"key":"19227_CR67","doi-asserted-by":"publisher","first-page":"E1316","DOI":"10.1073\/pnas.1525466113","volume":"113","author":"SE Marsh","year":"2016","unstructured":"Marsh, S. E. et al. The adaptive immune system restrains Alzheimer\u2019s disease pathogenesis by modulating microglial function. PNAS, 113, E1316\u2013E1325\u00a0(2016).","journal-title":"PNAS"},{"key":"19227_CR68","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1523\/JNEUROSCI.2774-16.2016","volume":"37","author":"GA Prieto","year":"2017","unstructured":"Prieto, G. A. et al.\u00a0 Pharmacological rescue of long-term potentiation in Alzheimer diseased synapses. J. Neurosci. 37, 1197\u20131212\u00a0(2017).","journal-title":"J. Neurosci."},{"key":"19227_CR69","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nature13800","volume":"515","author":"SH Choi","year":"2014","unstructured":"Choi, S. H. et al. A three-dimensional human neural cell culture model of Alzheimer\u2019s disease. Nature 515, 274\u2013278 (2014).","journal-title":"Nature"},{"key":"19227_CR70","doi-asserted-by":"publisher","first-page":"D745","DOI":"10.1093\/nar\/gky1113","volume":"47","author":"F Cunningham","year":"2019","unstructured":"Cunningham, F. et al. Ensembl 2019. Nucleic Acids Res. 47, D745\u2013D751 (2019).","journal-title":"Nucleic Acids Res."},{"key":"19227_CR71","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/nbt0816-888d","volume":"34","author":"NL Bray","year":"2016","unstructured":"Bray, N. L., Pimentel, H., Melsted, P. & Pachter, L. Erratum: Near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. 34, 888 (2016).","journal-title":"Nat. Biotechnol."},{"key":"19227_CR72","doi-asserted-by":"crossref","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","DOI":"10.1186\/s13059-014-0550-8"},{"key":"19227_CR73","doi-asserted-by":"publisher","unstructured":"Wickham, H. ggplot2: Elegant Graphics for Data Analysis. https:\/\/doi.org\/10.1007\/978-0-387-98141-3 (Springer-Verlag, 2009).","DOI":"10.1007\/978-0-387-98141-3"},{"key":"19227_CR74","unstructured":"Kolde, R. pheatmap: Pretty Heatmaps. (2019)."},{"key":"19227_CR75","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902.e21 (2019).","journal-title":"Cell"},{"key":"19227_CR76","doi-asserted-by":"crossref","unstructured":"Hafemeister, C. sctransform: Variance Stabilizing Transformations for Single Cell UMI Data. (2019).","DOI":"10.32614\/CRAN.package.sctransform"}],"updated-by":[{"DOI":"10.1038\/s41467-023-36930-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19227-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19227-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19227-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T05:41:59Z","timestamp":1723786919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19227-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,23]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["19227"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-19227-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,23]]},"assertion":[{"value":"29 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41467-023-36930-1","URL":"https:\/\/doi.org\/10.1038\/s41467-023-36930-1","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.B.J. is a co-inventor of patent WO\/2018\/160496 related to differentiation of human pluripotent stem cells into microglia. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5370"}}